- Report
- January 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1214EUR$1,250USD£1,047GBP
- Report
- March 2024
- 397 Pages
Global
From €7722EUR$7,950USD£6,661GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2671EUR$2,750USD£2,304GBP
- Report
- October 2023
- 145 Pages
Global
From €3059EUR$3,150USD£2,639GBP
- Report
- April 2023
- 120 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2671EUR$2,750USD£2,304GBP
- Report
- August 2022
- 30 Pages
Global
From €3157EUR$3,250USD£2,723GBP
- Report
- February 2020
- 253 Pages
Global
From €6070EUR$6,250USD£5,237GBP
- Report
- April 2018
- 38 Pages
Global
From €9713EUR$10,000USD£8,379GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,860USD£3,125GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,860USD£3,125GBP
- Report
- July 2022
- 220 Pages
Global
From €5565EUR$5,730USD£4,801GBP
Cariprazine is a medication used to treat mental disorders such as schizophrenia and bipolar disorder. It is a dopamine receptor partial agonist, meaning it binds to dopamine receptors in the brain and activates them to a lesser degree than dopamine itself. Cariprazine is thought to work by restoring the balance of certain natural substances in the brain, such as dopamine and serotonin. It is available in both oral and injectable forms.
Cariprazine is generally well-tolerated and has fewer side effects than other antipsychotic medications. Common side effects include nausea, headache, insomnia, and restlessness. It is important to note that cariprazine can cause serious side effects, such as an increased risk of death in elderly people with dementia-related psychosis.
Cariprazine is a relatively new medication and is not yet widely available. It is currently approved for use in the United States, Canada, and several European countries.
Some companies in the Cariprazine market include Gedeon Richter, Allergan, and Sunovion Pharmaceuticals. Show Less Read more